دورية أكاديمية
Characterization and biodistribution of under-employed gene therapy vector AAV7.
| العنوان: | Characterization and biodistribution of under-employed gene therapy vector AAV7. |
|---|---|
| المؤلفون: | Yost SA; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Firlar E; Institute of Quantitative Biomedicine and Rutgers CryoEM & Nanoimaging Facility, Rutgers, The State University of New Jersey , Piscataway, New Jersey, USA., Glenn JD; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Carroll HB; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Foltz S; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Giles AR; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Egley JM; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Firnberg E; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Cho S; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Nguyen T; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Henry WM; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Janczura KJ; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Bruder J; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Liu Y; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Danos O; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Karumuthil-Melethil S; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Pannem S; Invicro LLC , Needham, Massachusetts, USA., Yost V; Invicro LLC , Needham, Massachusetts, USA., Engelson Y; Invicro LLC , Needham, Massachusetts, USA., Kaelber JT; Institute of Quantitative Biomedicine and Rutgers CryoEM & Nanoimaging Facility, Rutgers, The State University of New Jersey , Piscataway, New Jersey, USA., Dimant H; Invicro LLC , Needham, Massachusetts, USA.; Emit Imaging , Baltimore, Maryland, USA., Smith JB; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA., Mercer AC; Research and Early Development, REGENXBIO Inc. , Rockville, Maryland, USA. |
| المصدر: | Journal of virology [J Virol] 2023 Nov 30; Vol. 97 (11), pp. e0116323. Date of Electronic Publication: 2023 Oct 16. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Washington Dc : American Society For Microbiology Original Publication: Baltimore, American Society for Microbiology. |
| مواضيع طبية MeSH: | Dependovirus*/genetics , Genetic Therapy* , Genetic Vectors*/genetics, Humans ; Capsid ; Capsid Proteins/genetics ; Phylogeny ; Tissue Distribution |
| مستخلص: | Importance: The use of adeno-associated viruses (AAVs) as gene delivery vectors has vast potential for the treatment of many severe human diseases. Over one hundred naturally existing AAV capsid variants have been described and classified into phylogenetic clades based on their sequences. AAV8, AAV9, AAVrh.10, and other intensively studied capsids have been propelled into pre-clinical and clinical use, and more recently, marketed products; however, less-studied capsids may also have desirable properties (e.g., potency differences, tissue tropism, reduced immunogenicity, etc.) that have yet to be thoroughly described. These data will help build a broader structure-function knowledge base in the field, present capsid engineering opportunities, and enable the use of novel capsids with unique properties. Competing Interests: All REGENXBIO employees earn salary and own stock in REGENXBIO, Inc. All Invicro employees earn salary from Invicro. |
| References: | Hum Gene Ther. 2013 May;24(5):526-32. (PMID: 23517473) Nat Commun. 2019 Aug 21;10(1):3760. (PMID: 31434885) Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):. (PMID: 33380465) Mol Ther Methods Clin Dev. 2020 Mar 17;17:601-611. (PMID: 32280726) Mol Ther. 2018 Feb 7;26(2):510-523. (PMID: 29175157) J Virol. 2004 Jun;78(12):6381-8. (PMID: 15163731) Mol Ther Methods Clin Dev. 2019 Mar 28;13:380-389. (PMID: 31024980) J Virol. 2020 Feb 28;94(6):. (PMID: 31826994) Nat Rev Genet. 2011 May;12(5):341-55. (PMID: 21499295) Gene Ther. 1999 Jun;6(6):973-85. (PMID: 10455399) Gene Ther. 2008 Jun;15(11):858-63. (PMID: 18418415) Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):28743-28753. (PMID: 33139572) Nat Biotechnol. 2009 Jan;27(1):59-65. (PMID: 19098898) Elife. 2019 May 22;8:. (PMID: 31115336) J Virol. 2021 Sep 9;95(19):e0084321. (PMID: 34260280) Mol Ther Methods Clin Dev. 2020 Apr 18;17:922-935. (PMID: 32405514) J Virol. 2014 Mar;88(5):2991-3003. (PMID: 24371066) Gene Ther. 2019 Dec;26(12):504-514. (PMID: 31570819) Nature. 2016 Feb 4;530(7588):108-12. (PMID: 26814968) Mol Ther Methods Clin Dev. 2022 May 29;26:52-60. (PMID: 35755945) Hum Gene Ther. 2010 Oct;21(10):1259-71. (PMID: 20497038) J Virol. 2012 Jul;86(13):7326-33. (PMID: 22514350) Clin Microbiol Rev. 2008 Oct;21(4):583-93. (PMID: 18854481) Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11854-9. (PMID: 12192090) Mol Ther Methods Clin Dev. 2018 May 08;10:1-7. (PMID: 30073177) Nat Commun. 2019 Jul 4;10(1):2958. (PMID: 31273195) Hum Gene Ther Methods. 2014 Apr;25(2):115-25. (PMID: 24328707) Hum Gene Ther. 2011 Sep;22(9):1143-53. (PMID: 21476867) Mol Ther. 2011 Jun;19(6):1070-8. (PMID: 21364538) J Virol. 2002 Jun;76(11):5711-9. (PMID: 11991999) J Biol Chem. 2011 Apr 15;286(15):13532-40. (PMID: 21330365) Glycobiology. 2012 Sep;22(9):1147-62. (PMID: 22513036) Acta Crystallogr F Struct Biol Commun. 2020 Feb 1;76(Pt 2):58-64. (PMID: 32039886) Nat Microbiol. 2019 Apr;4(4):675-682. (PMID: 30742069) Mol Ther. 2006 Sep;14(3):316-27. (PMID: 16824801) Viruses. 2021 Jan 13;13(1):. (PMID: 33450892) |
| معلومات مُعتمدة: | REGENXBIO (REGENXBIO Inc.) |
| فهرسة مساهمة: | Keywords: AAV; adeno-associated vectors; biodistribution; cryoelectron microscopy; gene therapy; virology |
| المشرفين على المادة: | 0 (Capsid Proteins) |
| تواريخ الأحداث: | Date Created: 20231016 Date Completed: 20231206 Latest Revision: 20231206 |
| رمز التحديث: | 20231206 |
| مُعرف محوري في PubMed: | PMC10688378 |
| DOI: | 10.1128/jvi.01163-23 |
| PMID: | 37843374 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1098-5514 |
|---|---|
| DOI: | 10.1128/jvi.01163-23 |